292 related articles for article (PubMed ID: 19357047)
1. Serum levels of interleukin (IL)-13, IL-17 and IL-18 in patients with ischemic heart disease.
Jafarzadeh A; Esmaeeli-Nadimi A; Nough H; Nemati M; Rezayati MT
Anadolu Kardiyol Derg; 2009 Apr; 9(2):75-83. PubMed ID: 19357047
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of interleukin (IL)-27 in patients with ischemic heart disease.
Jafarzadeh A; Nemati M; Rezayati MT
Cytokine; 2011 Nov; 56(2):153-6. PubMed ID: 21795063
[TBL] [Abstract][Full Text] [Related]
3. The association between infection burden in Iranian patients with acute myocardial infarction and unstable angina.
Jafarzadeh A; Nemati M; Tahmasbi M; Ahmadi P; Rezayati MT; Sayadi AR
Acta Med Indones; 2011 Apr; 43(2):105-11. PubMed ID: 21785173
[TBL] [Abstract][Full Text] [Related]
4. High sensitivity C-reactive protein and immunoglobulin G against Chlamydia pneumoniae and chlamydial heat shock protein-60 in ischemic heart disease.
Jafarzadeh A; Esmaeeli-Nadimi A; Shariati M
Iran J Immunol; 2008 Mar; 5(1):51-6. PubMed ID: 18319525
[TBL] [Abstract][Full Text] [Related]
5. Cytokines in patients with ischaemic heart disease or myocardial infarction.
Bossowska A; Kiersnowska-Rogowska B; Bossowski A; Galar B; Sowiński P
Kardiol Pol; 2003 Aug; 59(8):105-14. PubMed ID: 14560325
[TBL] [Abstract][Full Text] [Related]
6. High serum levels of rheumatoid factor and anti-phosphatidylserine antibody in patients with ischemic heart disease.
Jafarzadeh A; Poorgholami M; Nemati M; Rezayati MT
Iran J Immunol; 2011 Mar; 8(1):34-44. PubMed ID: 21427494
[TBL] [Abstract][Full Text] [Related]
7. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
[TBL] [Abstract][Full Text] [Related]
8. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of interleukin-18 in patients with stable and unstable angina pectoris.
Rosso R; Roth A; Herz I; Miller H; Keren G; George J
Int J Cardiol; 2005 Jan; 98(1):45-8. PubMed ID: 15676165
[TBL] [Abstract][Full Text] [Related]
10. The pro- and anti-inflammatory markers in patients with acute myocardial infarction and chronic stable angina.
Wojakowski W; Maslankiewicz K; Ochala A; Wyderka R; Zuk-Popiolek I; Flak Z; Mroz I; Tendera M
Int J Mol Med; 2004 Aug; 14(2):317-22. PubMed ID: 15254785
[TBL] [Abstract][Full Text] [Related]
11. [Levels of anti-inflammatory cytokines interleukin-2, interleukin-8, and soluble interleukin-2 receptor in blood of patients with various forms of ischemic heart disease].
Mazurov VI; Stvolov SV; Linetskaia NE; Baldueva IA
Ter Arkh; 2001; 73(12):14-7. PubMed ID: 11858100
[TBL] [Abstract][Full Text] [Related]
12. Differences in inflammatory and thrombotic markers between unstable angina and acute myocardial infarction.
Tousoulis D; Antoniades C; Bosinakou E; Kotsopoulou M; Tsoufis C; Marinou K; Charakida M; Stefanadi E; Vavuranakis M; Latsios G; Stefanadis C
Int J Cardiol; 2007 Feb; 115(2):203-7. PubMed ID: 16787670
[TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of Helicobacter pylori IgG and the virulence factor CagA in patients with ischaemic heart disease.
Jafarzadeh A; Esmaeeli-Nadimi A; Nemati M; Tahmasbi M; Ahmadi P
East Mediterr Health J; 2010 Oct; 16(10):1039-44. PubMed ID: 21222419
[TBL] [Abstract][Full Text] [Related]
14. [Plasma fibrinogen during the acute stage of angina or myocardial infarct].
de la Llata-Romero M; Cancino C; Cuan V; López-Santibáñez J; Silvia Oropeza E; Ariza-Andraca H
Gac Med Mex; 1997; 133(3):175-80; discussion 181. PubMed ID: 9303865
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-18/interleukin-10 ratio is an independent predictor of recurrent coronary events during a 1-year follow-up in patients with acute coronary syndrome.
Chalikias GK; Tziakas DN; Kaski JC; Kekes A; Hatzinikolaou EI; Stakos DA; Tentes IK; Kortsaris AX; Hatseras DI
Int J Cardiol; 2007 May; 117(3):333-9. PubMed ID: 16859776
[TBL] [Abstract][Full Text] [Related]
16. Serum profiles of matrix metalloproteinases and their tissue inhibitor in patients with acute coronary syndromes. The effects of short-term atorvastatin administration.
Tziakas DN; Chalikias GK; Parissis JT; Hatzinikolaou EI; Papadopoulos ED; Tripsiannis GA; Papadopoulou EG; Tentes IK; Karas SM; Chatseras DI
Int J Cardiol; 2004 Apr; 94(2-3):269-77. PubMed ID: 15093992
[TBL] [Abstract][Full Text] [Related]
17. Interaction between inflammation and thrombosis in acute coronary syndrome.
Lytvyn OI; Kopitsa MP; Petyunina OV
Kardiol Pol; 2004 Aug; 61(8):110-6; discussion 114-6. PubMed ID: 15457277
[TBL] [Abstract][Full Text] [Related]
18. Role of lipid, apolipoprotein levels and apolipoprotein E genotype in young Italian patients with myocardial infarction.
Scaglione L; Bergerone S; Gambino R; Imazio M; Macchia G; Cravetto A; Gaschino G; Baralis G; Rosettani E; Pagano G; Cassader M
Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):118-24. PubMed ID: 10464784
[TBL] [Abstract][Full Text] [Related]
19. Enhanced proinflammatory response of mononuclear cells to in vitro LPS-challenge in patients with ventricular fibrillation in the setting of acute myocardial infarction.
Elmas E; Hölzer L; Lang S; Popp T; Kälsch T; Wolpert C; Brueckmann M; Borggrefe M
Cytokine; 2008 Aug; 43(2):138-42. PubMed ID: 18571935
[TBL] [Abstract][Full Text] [Related]
20. [Coronary heart disease risk factors in Croatia and worldwide: results of the Interheart study].
Carević V; Rumboldt M; Rumboldt Z;
Acta Med Croatica; 2007 Jun; 61(3):299-306. PubMed ID: 17629106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
